Samantha Pacheco
Family · Albuquerque, NMNPI 1043841802
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $790 and has fallen 97.8% since, to $17 in 2024.
Across 100 payments — averaging $15.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$245
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$181
- Lilly USA, LLC$156
- Novo Nordisk$152
- Teva Pharmaceuticals USA, Inc.$136
- Vanda Pharmaceuticals Inc.$128
- plus $565 from 14 others
What the payments were for
- Food & beverage$1,563100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $245 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $181 |
| Lilly USA, LLC | 9 | $156 |
| Novo Nordisk | 9 | $152 |
| Teva Pharmaceuticals USA, Inc. | 7 | $136 |
| Vanda Pharmaceuticals Inc. | 6 | $128 |
| Merck | 7 | $95 |
| Amgen | 5 | $77 |
| AstraZeneca | 4 | $65 |
| Novartis | 4 | $62 |
| Boehringer Ingelheim | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Bayer | 2 | $33 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Amarin Pharma, Inc. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Braeburn Inc. | 1 | $17 |
| Optinose US, Inc. | 1 | $17 |
How this compares
$1,563 in reported general payments places this provider in the 85th percentile of 1,080 family providers in New Mexico.
Other family in Albuquerque
- Barbara FranklinAlbuquerque$28K
- Melanie DuranAlbuquerque$15K
- Irasema LlewellynAlbuquerque$14K
- Charles GallegosAlbuquerque$10K
- Marlyn NewbyAlbuquerque$9K
- Annmarie FoleyAlbuquerque$8K
- Aimee CasarezAlbuquerque$7K
- Rita SuharliAlbuquerque$6K
- Matthew TotterAlbuquerque$6K
- Roberta ChampouillonAlbuquerque$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.